Correction to AstraZeneca Earnings Article
November 12 2021 - 5:07AM
Dow Jones News
AstraZeneca PLC's coronavirus vaccine contributed $0.01 to
earnings per share in the third quarter, though the company lost
$0.03 per share from its development since the start of the year.
"AstraZeneca Swung to 3Q Loss Despite Higher Revenue; Continues to
Lose Money From Covid-19 Vaccine," at 0741 GMT, incorrectly said
that development of the vaccine shaved $0.01 off earnings in the
third quarter.
(END) Dow Jones Newswires
November 12, 2021 04:52 ET (09:52 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024